- Home
- / Bausch + Lomb
Bausch + Lomb
Stock Price
$15.5
2024-08-13
Market Capitalization
$5.4 B
2024-08-13
Revenue
$4.1 B
FY, 2023
Bausch + Lomb Summary
Company Summary
- Overview
- Bausch + Lomb is a company that develops, manufactures, and markets eye health products. It offers contact lenses, lens care products, over-the-counter eye care and supplements, Rx pharmaceuticals, optical accessories, and safety and industrial glasses. In addition, the company provides diagnostic systems and eye surgery equipment.
- Type
- Public
- Status
- Active
- Founded
- 1853
- HQ
- Vaughan, CA | view all locations
- Website
- https://www.bausch.com/
- Cybersecurity rating
- ESG rating
Table of Contents
Key People
Christina M. Ackermann, Executive Vice President, General Counsel and President, Ophthalmic Pharmaceuticals
Joseph Gordon, President, Global Consumer, Surgical and Vision Care
Dennis Asharin, Executive Vice President and Chief Global Manufacturing and Supply Chain Officer
Operating MetricsView all
Countries (Customers)
100
FY, 2022
Facility Space Owned, sq. ft.
3.4M
7.8%
FY, 2022
Facility Space Leased, sq. ft.
808K
FY, 2022
LocationsView all
45 locations detected
Vaughan, ON HQ
Canada
520 Applewood Crescent
Ballwin, MO
United States
499 Sovereign Ct
Clearwater, FL
United States
21 N Park Pl Blvd
Greenville, SC
United States
8507 Pelham Rd
Irvine, CA
United States
15272 Alton Pkwy #200
Lynchburg, VA
United States
1501 Graves Mill Rd
Bausch + Lomb Financials
Summary Financials
- Revenue (Q2, 2024)
- $1.2B
- Net income (Q2, 2024)
- ($148.0M)
- Cash (Q2, 2024)
- $285.0M
- EBIT (Q2, 2024)
- $26.0M
- Enterprise value
- $12.7B